戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 synthase), Sk2 (sphingosine kinase) and Ras (IMP dehydrogenase).
2 elieved by single amino acid replacements in IMP dehydrogenase.
3 ave been prepared as potential inhibitors of IMP dehydrogenase.
4  the most potent cofactor type inhibitors of IMP dehydrogenase.
5 nthosine 5'-monophosphate (XMP) catalyzed by IMP dehydrogenase.
6 d as inhibitors of the two isoforms of human IMP-dehydrogenase.
7                       Inosine monophosphate (IMP) dehydrogenase 2 (IMPDH2) is a rate-limiting enzyme
8                            Here we show that IMP dehydrogenase-2 (IMPDH2), the rate-limiting enzyme f
9                                  It inhibits IMP dehydrogenase, a rate-limiting enzyme in de novo syn
10 l functions of the IMPDH homologs aside from IMP dehydrogenase activity.
11                       MPA is an inhibitor of IMP dehydrogenase, an enzyme necessary for the de novo b
12 nery render yeast sensitive to inhibitors of IMP dehydrogenase and defective in inducing transcriptio
13 synthesis pathways-inosine-5'-monophosphate (IMP) dehydrogenase and cytosine triphosphate (CTP) synth
14 furin, or ribavirin, which are inhibitors of IMP dehydrogenase, as inducers.
15 tive in inducing transcription of one of the IMP dehydrogenase-encoding genes, IMD2.
16                         The putative Candida IMP dehydrogenase gene (IMH3) encodes a protein of 521 a
17                                           An IMP dehydrogenase gene was isolated from Candida albican
18 osyltransferase (DRTase, encoded by bb0426), IMP dehydrogenase (GuaB) and GMP synthase (GuaA) catalys
19 o key enzymes in purine salvage pathways are IMP dehydrogenase (GuaB) and GMP synthase (GuaA), encode
20 ymes, adenylosuccinate synthetase (PurA) and IMP dehydrogenase (GuaB) in these strains.
21 n cells unable to convert IMP to XMP or AMP (IMP dehydrogenase, guaB; adenylosuccinate synthetase, pu
22 ve-site sequence of At IMPDH conforms to the IMP dehydrogenase/guanosine monophosphate reductase moti
23 e conformation of IMP bound to human type II IMP dehydrogenase has been determined by two-dimensional
24  of ribavirin, suggesting that inhibition of IMP dehydrogenase (IMPDH) and reduction of intracellular
25                                              IMP dehydrogenase (IMPDH) catalyzes the NAD-dependent sy
26                                              IMP dehydrogenase (IMPDH) catalyzes the oxidation of IMP
27                                              IMP dehydrogenase (IMPDH) catalyzes the oxidation of IMP
28                                              IMP dehydrogenase (IMPDH) catalyzes the oxidation of IMP
29                                              IMP dehydrogenase (IMPDH) catalyzes the oxidation of IMP
30                                              IMP dehydrogenase (IMPDH) catalyzes the oxidation of ino
31                                              IMP dehydrogenase (IMPDH) catalyzes the pivotal step in
32                                              IMP dehydrogenase (IMPDH) catalyzes the rate-limiting st
33                                              IMP dehydrogenase (IMPDH) catalyzes two very different c
34                                              IMP dehydrogenase (IMPDH) controls a key regulatory node
35                                              IMP dehydrogenase (IMPDH) is an essential enzyme that ca
36                                              IMP dehydrogenase (IMPDH) is an essential enzyme that ca
37                                              IMP dehydrogenase (IMPDH) is the rate-limiting enzyme fo
38                                              IMP dehydrogenase (IMPDH) is the rate-limiting enzyme in
39                 Previously, we proposed that IMP dehydrogenase (IMPDH) was an essential factor for p5
40        The Bateman domain (CBS subdomain) of IMP dehydrogenase (IMPDH), a rate-limiting enzyme of the
41 e agent mizoribine and a potent inhibitor of IMP dehydrogenase (IMPDH).
42     Mycophenolic acid (MPA), an inhibitor of IMP-dehydrogenase (IMPDH), is used worldwide in transpla
43 ), which is a potent inhibitor of eukaryotic IMP dehydrogenases (IMPDHs).
44 inhibits aldolase and inosine monophosphate (IMP) dehydrogenase in a concentration-dependent manner.
45 stemin protein degradation in tumor cells by IMP dehydrogenase inhibition or by other small molecules
46 ld temperature, nutrient limitation, and the IMP dehydrogenase inhibitor mycophenolic acid (MPA).
47 tive secretory vacuoles, we hypothesize that IMP dehydrogenase inhibitors induce androgen-independent
48                                              IMP dehydrogenase is a rate-limiting enzyme involved in
49 itor of the de novo purine synthetic enzyme, IMP dehydrogenase, leads to the rapid disappearance of n
50                                              IMP dehydrogenase mRNAs are detected in both the yeast a
51 ds with extensive sequence similarity to the IMP dehydrogenases of Saccharomyces cerevisiae and vario
52      Inosine 5'-monophosphate dehydrogenase (IMP dehydrogenase or IMPDH) is a promising target for th
53 phenolic acid (MPA), a specific inhibitor of IMP dehydrogenases, per ml, whereas transformants hostin
54 ar motor switch protein and the guaB-encoded IMP dehydrogenase) were noninfectious, whereas four clon
55 bavirin (RBV) lies in its ability to inhibit IMP dehydrogenase, which lowers cellular GTP.